Affordable Access

Publisher Website

Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism.

Authors
Type
Published Article
Journal
Clinical and experimental nephrology
Publication Date
Volume
18
Issue
3
Pages
507–514
Identifiers
DOI: 10.1007/s10157-013-0844-2
PMID: 23903802
Source
Medline

Abstract

Both oral paricalcitol and calcitriol were equally efficacious in reducing serum iPTH but were associated with significantly higher serum calcium. Serum Ca × P product increased in the paricalcitol group and decreased in the calcitriol group. Serum hsCRP level and PFT were not affected by either treatment. A larger randomized controlled trial is indicated to confirm these initial findings.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments